Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014

Conclusions.
Reductions in vaccine-type IPD post-PCV13 were inferior to Australian experience with PCV7 and reports from high-income countries giving a PCV booster dose. Applicability of findings to other settings would depend on age of IPD onset, serotype profile, and timeliness of vaccination.

Source: Clinical Infectious Diseases - January 3, 2017 Category: Infectious Diseases Authors: Jayasinghe, S., Menzies, R., Chiu, C., Toms, C., Blyth, C. C., Krause, V., McIntyre, P. Tags: Major Article Source Type: research